Abstract
A 63-year-old man with a metastasising pancreatic glucagonoma is described, who presented with progressive deterioration of vision and bilateral central scotomata as the first symptom. This patient was treated with dacarbazine (DTIC) 250 mg/m2 IV daily for five consecutive days at 4-week intervals. The vision returned completely to normal, in a clinical and biochemical remission. Although there is no wide experience in treatment, the literature seems to indicate that DTIC should be the drug of choice in treating metastatic glucagonoma.
Central scotomata may be a new ‘paraneoplastic’ symptom and a key to the earlier diagnosis of the glucagonoma syndrome by ophthalmologists, just as necrolytic migratory erythema has been for the dermatologists.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Awirch A, Peetz M, Fletcher W: Dimethyltriazenoimidazole Carboxamide therapy of islet cell carcinoma of the pancreas. J Surg Oncol 17: 321–326 1981
Kessinger A, Foley JF, Lemon HM: Therapy of malignant APUD cell tumors, effectiveness of DTIC. Cancer 51: 790–794, 1983
Kessinger A, Lemon HM, Foley JF: The glucagonoma syndrome and its management. J Surg Oncol 9: 419–422, 1977
Khandekar JD, Oyer D, Miller HJ, et al: Neurologic involvement in glucagonoma syndrome. Response to combination chemotherapy with 5-fluorouracil and streptozotocin. Cancer 44: 2014–2016, 1979
Kurose T, Seino Y, Ishida H, et al: Successful treatment of metastastic glucagonoma with dacabarzine. Lancet 1: 621–622, 1984
Mallinson CN, Bloom SR, Warin AP, et al: A glucagonoma syndrome. Lancet 2: 1–5, 1974
Marynick SP, Fagadau WR, Duncan LA: Malignant glucagonoma syndrome: response to chemotherapy. Ann Intern Med 93: 453–454, 1980
Paulusma-de Waal JH, Bosman FT, Fischer HR, et al: The glucagonoma syndrome. Neth J Med 25: 127–133, 1982
Prinz RA, Badrinath K, Banerji M, et al: Operative and chemotherapeutic manzgement of malignant glucagon-producing tumors. Surgery 90: 713–719, 1981.
Prinz RA, Dorsch TR, Lawrence AM: Clinical aspects of glucagon-producing islet cell tumors. Am J Gastroenterol 76: 125–131, 1981
Prinz RA, Parenti AJ, Dorsch TR, et al: Glucagon producing islet cell tumors of the pancreas. Proc Inst Med Chic 32: 133, 1979
Strauss GM, Weitzman SA, Aoki TT: Dimethyltriazenoimidazole Carboxamide therapy of malignant glucagonoma. Ann Intern Med 90: 57–58, 1979
Vandersteen PR, Scheithauer BW: Glucagonoma syndrome. A clinicopathologic, immunocytochemical and ultrastructural study. J Am Acad Dermatol 12: 1032–1039, 1985
Wilkinson DS: Necrolytic migratory erythema with pancreatic carcinoma. Proc Royal Soc Med 64: 1197–1199, 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lambrecht, E.R., van der Loos, T.L.J.M. & van der Eerden, A.H.A.M. Retrobulbar neuritis as the first sign of the glucagonoma syndrome. Int Ophthalmol 11, 13–15 (1987). https://doi.org/10.1007/BF02027892
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02027892